Menzies School Of Health Research

This study tests a very short, 3-day course of the drug primaquine to cure vivax malaria and prevent it from returning. Current treatments take longer, which can lead to people not finishing them. The trial will include about 1,019 people with vivax malaria who have a normal G6PD…

This study looks at whether a drug called tafenoquine can be safely combined with two common malaria treatments (DHA-piperaquine or artesunate-pyronaridine) in adults with vivax malaria. The goal is to see if these combinations work better at preventing the malaria from returning…

This study tests whether a single dose of an RSV-fighting antibody, given at 6 months old, can prevent serious lung infections in Aboriginal and Torres Strait Islander infants. Around 1,000 babies will either receive the antibody or standard care, and researchers will track infec…